Pangenomic Study During Alcoholic Cirrhosis

NCT ID: NCT01065233

Last Updated: 2021-09-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1325 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-10-23

Study Completion Date

2013-07-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hepatocellular carcinoma (HCC) is a frequent complication of cirrhosis. Occurrence of HCC could be linked with multiple functional region of genome.

The determining of a genomic mapping of " single nucleotide polymorphisms " (SNPs) permit to perform some genetic link studies with pathologies without clear hereditary disposition.

In this study, the investigators will identify predictives genetic polymorphism of HCC.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alcoholic Cirrhosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

alcoholic cirrhosis with viral infection

patient with alcoholic cirrhosis with viral infection (300 patients)

DNA extraction

Intervention Type GENETIC

DNA extraction of blood sample for DNAship analysis

alcoholic cirrhosis without viral infection

patient with alcoholic cirrhosis without viral infection

DNA extraction

Intervention Type GENETIC

DNA extraction of blood sample for DNAship analysis

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

DNA extraction

DNA extraction of blood sample for DNAship analysis

Intervention Type GENETIC

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 35 to 70 years old
* Compensated cirrhosis or not
* Caucasian origin of the parents
* Patient with cirrhosis (histological proof or obvious)

Exclusion Criteria

* HIV, HBV, HCV positive
* Known Homozygotia (C282Y+/+)
* Important hepatocytary iron overload for patient with resection
* HCC non histologically prooved
Minimum Eligible Age

35 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Nantes University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Nantes UH

Nantes, , France

Site Status

Jean Verdier UH

Paris, , France

Site Status

Paul Brousse UH

Paris, , France

Site Status

Rennes UH

Rennes, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Archambeaud I, Auble H, Nahon P, Planche L, Fallot G, Faroux R, Gournay J, Samuel D, Kury S, Feray C. Risk factors for hepatocellular carcinoma in Caucasian patients with non-viral cirrhosis: the importance of prior obesity. Liver Int. 2015 Jul;35(7):1872-6. doi: 10.1111/liv.12767. Epub 2015 Jan 21.

Reference Type DERIVED
PMID: 25522809 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BRD/07/08-M

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

HCC Innervation Assessment
NCT06886763 ACTIVE_NOT_RECRUITING